Efficacy of inductor of endogenous interferon's, cyclopheroni, in treatment of children with frequent acute respiratory infection (FARI)

L. Schostakovich-Koretskaya, I. Vysochyna, O. Kryvusha (Dnipropetreovsk, Ukraine)

Source: Annual Congress 2001 - Immune deficiencies and the lung in childhood
Session: Immune deficiencies and the lung in childhood
Session type: Oral Presentation
Number: 3437
Disease area: Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Schostakovich-Koretskaya, I. Vysochyna, O. Kryvusha (Dnipropetreovsk, Ukraine). Efficacy of inductor of endogenous interferon's, cyclopheroni, in treatment of children with frequent acute respiratory infection (FARI). Eur Respir J 2001; 16: Suppl. 31, 3437

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Evaluation of efficacy of interferon inducer in treatment of the recurrent acute respiratory viral infections in children
Source: Annual Congress 2012 - Fungal, viral and other infections
Year: 2012


The efficacy of multiple use of interferon-gamma inducer in treatment of recurrent acute respiratory viral infections in children with bronchial asthma
Source: Annual Congress 2013 –Preschool wheeze
Year: 2013

Current treatments for respiratory infections in children
Source: Annual Congress 2005 - PG5 - Paediatrics: respiratory infections in children
Year: 2005


The efficacy of the immunometabolic treatment with selenium (se) in preschool children with recurrent respiratory tract infections (rrti)
Source: Annual Congress 2009 - Host factors in paediatric bacterial respiratory infection
Year: 2009

Short-term survival of acute respiratory distress syndrome patients due to influenza virus infection alone: a cohort study
Source: ERJ Open Res, 6 (4) 00587-2020; 10.1183/23120541.00587-2020
Year: 2020



Analysis of serum cytokine levels before and after isoprinosine treatment in children with acute viral respiratory infections
Source: Annual Congress 2010 - From viral bronchiolitis to recurrent pneumonia in childhood: diagnosis, treatment and underlying factors
Year: 2010

Duration of therapy in hospitalised patients with CAP
Source: Annual Congress 2007 - An international perspective of the management of hospitalised patients with community-acquired pneumonia
Year: 2007


Lower respiratory tract infection (LRTI): are there differences of microbial spectrum in stable phase (SP) of COPD and during acute exacerbation (AE)?
Source: Annual Congress 2009 - COPD: exacerbation and clinical problems
Year: 2009


Eosinopenia in COPD patients with severe acute respiratory virus 2 (Sars-CoV-2) infection as a potential fatal outcome predictor
Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects
Year: 2021


Clinical and virusological effectiveness study of ultralow doses of antibodies to interferon-gamma in treatment of acute respiratory viral infections and influenza in children
Source: Annual Congress 2009 - Diagnosis and treatment of viral respiratory infections in early childhood
Year: 2009

Antibiotics in acute exacerbations: what do we need?
Source: Annual Congress 2005 - Infection and acute exacerbation of COPD: what do we know?
Year: 2005

Effect of inhaled SNG001 (interferon-beta 1a) on sputum and blood antiviral biomarkers following a respiratory virus infection in asthmatic subjects
Source: Annual Congress 2013 –Interesting cases of respiratory infections
Year: 2013

Interferon inducer in treatment of acute respiratory viral infections in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014

State of immunity at children with a bronchial asthma (BA) and acute respiratory virus infection (ARVI)
Source: Eur Respir J 2007; 30: Suppl. 51, 644s
Year: 2007

Impact of respiratory syncytial virus infection and palivizumab on severe acute lower respiratory infection during the first 6 months of life in a cohort of Colombian infants.
Source: International Congress 2018 – Clinical problems in paediatric pulmonology
Year: 2018

Reducing inappropriate antibiotic use in lower respiratory tract infection (LRTI); a quality improvement study
Source: Annual Congress 2013 –Recent developments in pneumonia
Year: 2013


Respiratory pathogens, immunodeficiency or systemic response – What comes first in the etiology of severe community-acquired pneumonia (sCAP)
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013


Spread of carriage of pneumonia and acute respiratory diseases (ARS) agents in recruits
Source: Eur Respir J 2005; 26: Suppl. 49, 144s
Year: 2005

Prospective study on the contribution of respiratory syncytial virus (RSV) to acute lower respiratory tract infections (ALRTI) in young hospitalised children
Source: Eur Respir J 2004; 24: Suppl. 48, 622s
Year: 2004

The frequency of respiratory infections in patients with chronic hepatitis C treated with pegylated-Interferon
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015